HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coty Enters Fragrance Deal With Far-Reaching Elite Modeling Network

This article was originally published in The Rose Sheet

Executive Summary

Coty Inc. will launch four new scents through a partnership with Elite World SA, a global modeling network that manages 2,300 models on five continents.

You may also be interested in...



Parlux Has “Enough" Celeb Fragrances, Says CEO, Reaffirming New Direction

Still reeling from the loss of the Guess fragrance license, which contributed to a 37% decline in sales for the third quarter, and in light of recent frustrations surrounding the launch of Reb'l Fleur by Rihanna, Parlux Fragrances CEO Frederick E. Purches maintains that it’s time for the company to change direction.

Coty's Philosophy: Expand Portfolio With Higher-Growth Skin Care

Coty Inc. marches toward its goal of becoming a $7 billion beauty company, diversifying its fragrance-heavy portfolio with the Nov. 23 acquisition of prestige skin-care, bath and body brand philosophy.

Euromonitor: Value Shopping, Gender-Blurring Among Top Consumer Trends For 2106

A new report from market-research firm Euromonitor International suggests that global consumption in the coming year will see a blend of established, new and counter trends, challenging the way consumers live and shop. Within beauty, marketers may seize on the trends of value shopping, gender-blurring and embracing of aging to reach discriminating consumers in 2016.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017788

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel